Inflammation-related molecular signatures involved in the anticancer activities of brigatinib as well as the prognosis of EML4-ALK lung adenocarcinoma patient.
炎症相关分子特征参与布加替尼的抗癌活性以及 EML4-ALK 肺腺癌患者的预后
期刊:Acta Pharmacologica Sinica
影响因子:8.4
doi:10.1038/s41401-024-01230-x
Ge Fu-Jing, Dai Xiao-Yang, Qiu Yao, Liu Xiang-Ning, Zeng Chen-Ming, Xu Xiao-Yuan, Chen Yi-Dan, Zhu Hong, He Qiao-Jun, Gai Ren-Hua, Ma Sheng-Lin, Chen Xue-Qin, Yang Bo
